| Names | |
|---|---|
|
Preferred IUPAC name
1-{3-[4-(Piperidin-1-ylmethyl)phenoxy]propyl}piperidine
|
|
|
Systematic IUPAC name
1-({4-[3-(Piperidin-1-yl)propoxy]phenyl}methyl)piperidine
|
|
| Identifiers | |
|
3D model (JSmol)
|
|
| Abbreviations | JNJ-5207852 |
| ChEBI | |
| ChemSpider | |
| MeSH | JNJ-5207852 |
|
PubChem CID
|
|
|
|
|
|
| Properties | |
| C20H32N2O | |
| Molar mass | 316.480 g/mol |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
|
|
|
| Infobox references | |
JNJ-5207852 is a histamine antagonist selective for the H3 subtype. It has stimulant and nootropic effects in animal studies, and has been suggested as a possible treatment for memory defects associated with epilepsy. JNJ-5207852 itself did not progress to clinical development due to poor pharmacokinetic characteristics, but the related compound JNJ-17216498 is currently in Phase II clinical trials for the treatment of narcolepsy.